KUALA LUMPUR, Jan 22 — Only 51 cases (5.2 per cent) of 984 Adverse Event Following Immunisation (AEFI) cases for Covid-19 vaccine booster shots, which is equal to a rate of 0.005 reports for every 1,000 doses, are classified as serious as of January 20.

KUALA LUMPUR, Jan 7 — CanSino’s single-dose Convidecia vaccine has obtained conditional approval as a booster shot from Malaysia’s Drug Control Authority (DCA), which is under the National Pharmaceutical Regulatory Agency (NPRA).

KUALA LUMPUR, Nov 26 — The Malaysian government’s approval for the use of cannabis-based products for medical purposes has opened the floodgates for more studies by local researchers on the benefits and potential of drugs such as marijuana.

KUALA LUMPUR, Nov 17 — The 366th Drug Control Authority (DCA) meeting today agreed to give conditional approval for the use of AstraZeneca and CoronaVac vaccines as COVID-19 booster dose to individuals aged 18 and above after receiving the primary series of vaccination from the same type (homologous).

PUTRAJAYA, Nov 16 — The National Pharmaceutical Regulatory Agency (NPRA) has approved the shelf life extension for two Covid-19 vaccines, namely ‘CoronaVac Suspension for Injection Covid-19 Vaccine (Vero Cell), Inactivated’ (CoronaVac) and ‘Comirnaty Concentrate for Dispersion for Injection’ (Comirnaty).

KUALA LUMPUR, Nov 12 — A total of eight applications for special financial assistance due to adverse side effects from Covid-19 vaccines involving RM132,500 have been approved, and are being processed, according to the Health Ministry (MOH).

PUTRAJAYA, Aug 14 — Teenagers, aged from 12 to 15, will be given vaccine injections but priority is for individuals with certain health problems, said Health director-general Tan Sri Dr Noor Hisham Abdullah.

KUALA LUMPUR, Aug 6 — The activities of importing, advertising, selling, manufacturing, including compounding, Ivermectin as a Covid-19 treatment are for the purpose of clinical trials only, said Malaysian Pharmacists Society (MPS) president Amrahi Buang.

SHAH ALAM, July 7 — The Selangor Health Department (JKNS) pharmaceutical services enforcement officers confiscated 101 boxes of traditional Chinese medicine (TCM) called Lianhua Qingwen Jiaonang worth around RM2,500 from a premise in Petaling Jaya (PJ), Selangor last Thursday (July 1).

PUTRAJAYA, June 20 — The Health Ministry is studying whether the time interval for the second AstraZeneca vaccine dose can be shortened from 12 weeks to six weeks, Health Minister Datuk Seri Dr Adham Baba said.

KUALA LUMPUR, June 17 — Experts lauded the Drug Control Authority’s (DCA) approval for the use of the Pfizer vaccine for children aged 12 and above but urged the government to speed up the vaccination process for them.

KUALA LUMPUR, June 5 — The National Pharmaceutical Regulatory Agency (NPRA) has approved a clinical study of another Covid-19 vaccine, said Health director-general Tan Sri Dr Noor Hisham Abdullah.

KUALA LUMPUR, May 24 — Prime Minister Tan Sri Muhyiddin Yassin yesterday said that the government has no objection if certain quarters want to purchase their own Covid-19 vaccines, but they must first obtain approval from the National Pharmaceutical Regulatory Agency (NPRA).

KUALA LUMPUR, April 23 — The 356th Drug Control Authority (DCA) meeting today agreed to approve the conditional registration for the CoronaVac Suspension for Injection Covid-19 Vaccine (Vero Cell), Inactivated’ for use during disasters.

PUTRAJAYA, March 24 — The AstraZeneca Covid-19 vaccine is safe for use in Malaysia, said Health Minister Datuk Seri Dr Adham Baba.

KUALA LUMPUR, March 3 — The first batch delivery of AstraZeneca Covid-19 vaccine, to Malaysia is expected to arrive in the second quarter of this year, said the pharmaceutical company.

KUALA LUMPUR, Feb 25 — Pregnant women and breastfeeding mothers, who have fears that they are at high risk of Covid-19 infection are probably considering vaccination as a prevention measure.

KUALA LUMPUR, Feb 18 — The Covid-19 vaccination consent form which has gone viral on social media is not the final version of the form to be used in the national vaccination programme.

KUALA LUMPUR, Feb 16 — There is no short cut for Covid-19 vaccines to enter the Malaysian market as they are subject to strict conditions to ensure they are safe, effective and of quality.

KUALA LUMPUR, Feb 16 — A total of 312,390 doses of the Pfizer-BioNTech Covid-19 vaccine will be flown in as the first shipment to Malaysia.